Compare NICE Ltd (NICE) vs Koninklijke Philips NV (PHG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NICE Ltd vs Koninklijke Philips NV — how do they compare? NICE Ltd trades at $98.12 (market cap $5.94B), while Koninklijke Philips NV trades at $25.03 (market cap $24.84B). The key difference: Koninklijke Philips NV is far larger — about 4.2× NICE Ltd's market cap, and Koninklijke Philips NV pays a 4.01% dividend while NICE Ltd pays none. Which is the better fit depends on your goals.
| NICE | PHG | |
|---|---|---|
Market Cap | $5.94B | $24.84B |
Sector | Technology | Health |
52-Week High | $153.44 | $32.91 |
52-Week Low | $83.15 | $25.02 |
Enterprise Value | $5.67B | $31.44B |
Dividend Yield | — | 4.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NICE stock trades at $101.47, down 3.82% in the last session, reflecting near-term bearish technical signals. The company maintains strong fundamentals with a P/E of 14.77 and robust profitability, including a 65.12% gross margin and consistent earnings beats in recent quarters. Recent news highlights AI platform deployments with major clients like AOK PLUS and Bluecrest, reinforcing growth in the CX segment. Analyst consensus remains positive with a $118.67 price target, though technical indicators suggest caution amid a bearish overall signal.
The outlook for NICE is supported by solid cloud and AI revenue growth, upward EPS guidance, and a debt-light balance sheet. Key risks include execution challenges in scaling AI offerings and competitive pressures in the customer engagement software market. With no sell ratings from analysts and institutional accumulation, the stock presents a value opportunity for long-term investors despite near-term volatility.
PHG trades at $25.29, down 2.32% today, with a bearish technical signal but strong recent earnings beats. The company reported Q2 2026 EPS of $0.57 versus $0.40 expected, continuing a trend of profitability after a turnaround from losses in prior years. Recent news highlights product launches in health technology and a $33.7 million award for AI-enabled stroke care (Business Wire, 2026-08-26).
The outlook is mixed: fundamentals show improving margins and cash flow, but technical indicators and a majority hold analyst rating suggest near-term caution. Key risks include competitive pressures and execution of growth initiatives, while institutional buying activity indicates underlying confidence.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →About Koninklijke Philips NV
Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →
